Terms: = Liver cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
4630 results:
1.
Waziri P; Auta R; Imam MU; Chindo BA; Ladan Z; Mohammed Z; Wayah S; Mohammed J; Tahir MI; Ahmad AE; Alhassan Y; Tyoapine D; Agbaji AS
J Evid Based Integr Med; 2024; 29():2515690X241251558. PubMed ID: 38689490
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
Abo-Salem HM; El Souda SSM; Shafey HI; Zoheir KMA; Ahmed KM; Mahmoud K; Mahrous KF; Fawzy NM
Sci Rep; 2024 Apr; 14(1):9636. PubMed ID: 38671055
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Analyses of Primary liver cancer Cell Lines: Correspondence With Morphological Features of Original Tumors.
Akiba J; Ogasawara S; Yano H
Cancer Genomics Proteomics; 2024; 21(3):260-271. PubMed ID: 38670592
[TBL] [Abstract] [Full Text] [Related]
4. Somatic Mutations in Surgically Treated Colorectal liver Metastases: An Overview.
Wang J; Botvinov J; Bhatt AJ; Beyer K; Kreis ME; Adam M; Alseidi A; Margonis GA
Cells; 2024 Apr; 13(8):. PubMed ID: 38667294
[TBL] [Abstract] [Full Text] [Related]
5. The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy.
Du J; Zhang E; Huang Z
Front Immunol; 2024; 15():1358306. PubMed ID: 38665910
[TBL] [Abstract] [Full Text] [Related]
6. Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma.
Sang C; Yan L; Lin J; Lin Y; Gao Q; Shen X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):199. PubMed ID: 38627278
[TBL] [Abstract] [Full Text] [Related]
7. Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human liver cancer Cells.
Alsulays BB; Aodah AH; Ahmed MM; Anwer MK
Int J Nanomedicine; 2024; 19():3461-3473. PubMed ID: 38617799
[TBL] [Abstract] [Full Text] [Related]
8. Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma.
Raghav A; Jeong GB
Cells; 2024 Apr; 13(7):. PubMed ID: 38607076
[TBL] [Abstract] [Full Text] [Related]
9. [High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
Chen H; Li Z; Wang M; Lu L; Tang Q; Luo L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):455-464. PubMed ID: 38597436
[TBL] [Abstract] [Full Text] [Related]
10. Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status.
Kim MY; Park ER; Cho EH; Park SH; Han CJ; Kim SB; Gu MB; Shin HJ; Lee KH
Sci Rep; 2024 Apr; 14(1):7997. PubMed ID: 38580756
[TBL] [Abstract] [Full Text] [Related]
11. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract] [Full Text] [Related]
12. Pre-enrichment-free detection of hepatocellular carcinoma-specific ctDNA via PDMS and MEMS-based microfluidic sensor.
Çağlayan Arslan Z; Okan M; Külah H
Mikrochim Acta; 2024 Apr; 191(5):229. PubMed ID: 38565645
[TBL] [Abstract] [Full Text] [Related]
13. Dioon rzedowskii: An antioxidant, antibacterial and anticancer plant extract with multi-faceted effects on cell growth and molecular signaling.
Negm WA; Elekhnawy E; Mahgoub S; Ibrahim HA; Ibrahim Elberri A; Abo Mansour HE; Mosalam EM; Moglad E; Alzahraa Mokhtar F
Int Immunopharmacol; 2024 May; 132():111957. PubMed ID: 38554441
[TBL] [Abstract] [Full Text] [Related]
14. Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma.
Kacar Z; Slud E; Levy D; Candia J; Budhu A; Forgues M; Wu X; Raziuddin A; Tran B; Shetty J; Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Bhudhisawasdi V; Lertprasertsuke N; Auewarakul C; Sangrajrang S; Mahidol C; Ruchirawat M; Wang XW
Commun Biol; 2024 Mar; 7(1):383. PubMed ID: 38553628
[TBL] [Abstract] [Full Text] [Related]
15. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract] [Full Text] [Related]
16. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
17. [Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population].
Xie C; Lin BL; Deng H; Zhang XH; Zhao QY; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):140-147. PubMed ID: 38514263
[No Abstract] [Full Text] [Related]
18.
Wu TH; Lin TY; Yang PM; Li WT; Yeh CT; Pan TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474318
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of the cytotoxic activity of sorafenib-loaded camel milk casein nanoparticles against hepatocarcinoma cells.
Mittal A; Mahala N; Dhanawade NH; Dubey SK; Dubey US
Biotechnol J; 2024 Mar; 19(3):e2300449. PubMed ID: 38472095
[TBL] [Abstract] [Full Text] [Related]
20. COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.
Liu J; Han D; Xuan J; Xie J; Wang W; Zhou Q; Chen K
Aging (Albany NY); 2024 Mar; 16(6):5264-5287. PubMed ID: 38466642
[TBL] [Abstract] [Full Text] [Related]
[Next]
